BORA PHARMACEUTICALS monthly revenue
BORA PHARMACEUTICALS LTD
| Period | Released | Revenue (NT$) | MoM % | YoY % | YTD Rev (NT$) |
|---|---|---|---|---|---|
| Jun 2026 | Jul 15, 2026 | NT$2.3B | +8.7% | +39.2% | NT$9.9B |
| May 2026 | Jun 17, 2026 | NT$2.1B | +42.5% | +40.2% | NT$7.6B |
| Apr 2026 | May 17, 2026 | NT$1.5B | -2.9% | -27.5% | NT$5.5B |
| Mar 2026 | Apr 17, 2026 | NT$1.5B | +15.2% | +6.3% | NT$4B |
| Feb 2026 | Mar 17, 2026 | NT$1.3B | +16.1% | -23.2% | NT$2.5B |
| Jan 2026 | — | NT$1.1B | — | -30.2% | NT$1.1B |
| Dec 2025 | — | NT$1.7B | — | -16.6% | NT$19.8B |
| Nov 2025 | — | NT$1.5B | — | -10.8% | NT$18.1B |
| Oct 2025 | — | NT$1.7B | — | -17.9% | NT$16.6B |
| Sep 2025 | — | NT$1.7B | — | -15.0% | NT$14.9B |
| Aug 2025 | — | NT$1.4B | — | -26.6% | NT$13.2B |
| Jul 2025 | — | NT$1.8B | — | +4.5% | NT$11.8B |
| Jun 2025 | — | NT$1.7B | — | -2.7% | NT$10B |
| May 2025 | — | NT$1.5B | — | -10.7% | NT$8.4B |
| Apr 2025 | — | NT$2B | — | +22.8% | NT$6.8B |
| Mar 2025 | — | NT$1.5B | — | +94.9% | NT$4.8B |
| Feb 2025 | — | NT$1.7B | — | +96.3% | NT$3.4B |
| Jan 2025 | — | NT$1.6B | — | +33.6% | NT$1.6B |
| Dec 2024 | — | NT$2B | — | +107.9% | NT$19.3B |
| Nov 2024 | — | NT$1.7B | — | +49.4% | NT$17.3B |
| Oct 2024 | — | NT$2.1B | — | +85.9% | NT$15.6B |
| Sep 2024 | — | NT$2B | — | +99.2% | NT$13.5B |
| Aug 2024 | — | NT$1.9B | — | +88.5% | NT$11.5B |
| Jul 2024 | — | NT$1.7B | — | +61.1% | NT$9.6B |
Values are shown in billions of TWD. Latest period: Jun 2026. Updated 2026-07-09. Source: Company websiteTaiwan public company filings
Monthly Sales is available publicly. Financials, KPIs, reports, transcripts and the rest of Research require the Research tier.